lovastatin has been researched along with Obesity in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 6 (40.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christopher-Stine, L; Isackson, PJ; Kitzmiller, JP; Luzum, JA; Ma, C; Nguyen, LM; Ochs-Balcom, HM; Peltier, W; Tarnopolsky, M; Vladutiu, GD; Weisman, M; Wortmann, RL | 1 |
| Choi, MS; Jeon, SM; Lee, SA | 1 |
| Girotra, S; Mittleman, MA; Mukamal, KJ; Wee, CC; Weinstein, AR | 1 |
| Correia, JF; de Oliveira, LF; Ferreira, EA; Filho, DW; Gris, EF; Pedrosa, RC; Rebello, JM | 1 |
| Melone, M; Palyha, O; Rashid, S; Strack, A; Wilsie, L | 1 |
| Hsu, YW; Lee, CL; Pan, TM; Wen, JY | 1 |
| Jacobson, MS; Kohn, M | 1 |
| Kasiske, BL; Keane, WF; Kim, Y; O'Donnell, MP; Schmitz, PG | 1 |
| Bézard, J; Blond, JP; Georges, B; Maniongui, C | 1 |
| Kuiper, JJ | 1 |
| Mann, JI | 1 |
| Bressler, P; DeFronzo, RA; Kudolo, GB | 1 |
| Fuh, MM; Hung, YJ; Jeng, C; Kuo, SW; Pei, D; Wu, DA | 1 |
| Cleary, MP; Kasiske, BL; Keane, WF; O'Donnell, MP | 1 |
| Jurin, RR; McCune, SA | 1 |
1 review(s) available for lovastatin and Obesity
| Article | Year |
|---|---|
Cholesterol (and cardiovascular risk) in adolescence.
Topics: Adolescent; Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Humans; Lovastatin; Obesity; Risk Factors; Simvastatin | 2004 |
1 trial(s) available for lovastatin and Obesity
| Article | Year |
|---|---|
The relationship between obesity and atherosclerotic progression and prognosis among patients with coronary artery bypass grafts the effect of aggressive statin therapy.
Topics: Anticoagulants; Body Mass Index; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Disease Progression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Obesity; Postoperative Period; Prognosis; Prospective Studies; Warfarin | 2008 |
13 other study(ies) available for lovastatin and Obesity
| Article | Year |
|---|---|
Clinical features related to statin-associated muscle symptoms.
Topics: Aged; Atorvastatin; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Logistic Models; Lovastatin; Male; Medical History Taking; Middle Aged; Muscle Weakness; Muscular Diseases; Myalgia; Obesity; Odds Ratio; Pravastatin; Retrospective Studies; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Smoking; White People | 2019 |
Antiobesity and vasoprotective effects of resveratrol in apoE-deficient mice.
Topics: Animals; Anti-Obesity Agents; Anticholesteremic Agents; Aorta; Apolipoproteins E; Arteriosclerosis; Diet, Atherogenic; Humans; Lovastatin; Male; Mice; Mice, Knockout; Obesity; Protective Agents; Resveratrol; Stilbenes | 2014 |
The 2',4',6'-trihydroxyacetophenone isolated from Myrcia multiflora has antiobesity and mixed hypolipidemic effects with the reduction of lipid intestinal absorption.
Topics: Acetophenones; Animals; Anti-Obesity Agents; Cholesterol; Diet, High-Fat; Glucosides; Hypolipidemic Agents; Intestinal Absorption; Lactones; Lipase; Lipids; Lovastatin; Male; Mice; Myrica; Obesity; Orlistat; Pancreas; Plant Extracts; Rats; Rats, Wistar; Triglycerides; Weight Gain | 2011 |
Discovery of a new role of human resistin in hepatocyte low-density lipoprotein receptor suppression mediated in part by proprotein convertase subtilisin/kexin type 9.
Topics: Dose-Response Relationship, Drug; Dyslipidemias; Hep G2 Cells; Hepatocytes; Humans; Immunoprecipitation; Lovastatin; Models, Biological; Obesity; Proprotein Convertases; Real-Time Polymerase Chain Reaction; Receptors, LDL; Resistin; RNA, Messenger; Subtilisin | 2012 |
Monascus-fermented yellow pigments monascin and ankaflavin showed antiobesity effect via the suppression of differentiation and lipogenesis in obese rats fed a high-fat diet.
Topics: Adipocytes; Animals; Anti-Obesity Agents; CCAAT-Enhancer-Binding Protein-alpha; CCAAT-Enhancer-Binding Protein-beta; Cell Differentiation; Creatine Kinase; Diet, High-Fat; Dose-Response Relationship, Drug; Fermentation; Flavins; Heterocyclic Compounds, 3-Ring; Lipogenesis; Lipolysis; Lovastatin; Male; Membrane Transport Proteins; Monascus; Obesity; PPAR gamma; Rats; Rats, Sprague-Dawley | 2013 |
Lovastatin retards the progression of established glomerular disease in obese Zucker rats.
Topics: Animals; Cell Division; Cells, Cultured; Glomerular Mesangium; Glomerulosclerosis, Focal Segmental; Hyperlipidemias; Lovastatin; Male; Obesity; Rats; Rats, Zucker; Time Factors | 1993 |
Effect of simvastatin on desaturase activities in liver from lean and obese Zucker rats.
Topics: Animals; Anticholesteremic Agents; Delta-5 Fatty Acid Desaturase; Fatty Acid Desaturases; Fatty Acids; Fatty Acids, Unsaturated; In Vitro Techniques; Linoleoyl-CoA Desaturase; Lovastatin; Male; Microsomes, Liver; Obesity; Phospholipids; Rats; Rats, Zucker; Simvastatin | 1993 |
Effects of weight reduction and angiotensin-converting enzyme inhibition on IgA nephropathy-associated proteinuria.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Cholesterol; Diet, Reducing; Female; Glomerulonephritis, IGA; Hematuria; Humans; Lisinopril; Lovastatin; Middle Aged; Obesity; Proteinuria; Weight Loss | 1996 |
The role of nutritional modifications in the prevention of macrovascular complications of diabetes.
Topics: Antioxidants; Body Mass Index; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diet Therapy; Energy Intake; Energy Metabolism; Humans; Lovastatin; Minerals; Obesity; Simvastatin; Vitamins | 1997 |
Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: effect of hyperinsulinemia and lovastatin treatment.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Lovastatin; Male; Middle Aged; Obesity; Phospholipases A | 1997 |
Effects of lovastatin and gemfibrozil in subjects with high ratios of total cholesterol to high-density lipoprotein cholesterol.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Glucose; Cholesterol; Cholesterol, HDL; Female; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Insulin; Leptin; Lovastatin; Male; Middle Aged; Obesity; Proteins | 1999 |
Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats.
Topics: Albuminuria; Animals; Cholesterol; Clofibrate; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Hyperlipidemias; Lovastatin; Male; Obesity; Rats; Rats, Zucker; Triglycerides | 1988 |
Effect of mevinolin on cholesterol metabolism in obese and lean Zucker rats.
Topics: Animals; Blood Glucose; Cholesterol; Female; Liver; Lovastatin; Naphthalenes; Obesity; Rats; Rats, Zucker; Triglycerides | 1987 |